SUSTAINED EFFICACY IS ACHIEVED WITH REPEAT COURSES OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WITH AN INADEQUATE RESPONSE TO ONE OR MORE TNF INHIBITORS (TNF-IR)

被引：0
|
作者：
Keystone, Edward C. [1 ]
Fleischmann, Roy M. [2 ]
Emery, Paul [3 ]
Dougados, Maxime [4 ]
Baldassare, Andrew R. [5 ]
Armstrong, Gillian K. [6 ]
Linnik, Matthew [7 ]
Reynard, Mark [6 ]
Tyrrell, Helen [6 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Leeds Gen Infirm, Leeds, W Yorkshire, England
[4] Hop Cochin, F-75674 Paris, France
[5] St Louis Univ, St Louis, MO 63103 USA
[6] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[7] Biogen Idec Inc, San Diego, CA USA
来源：
RHEUMATOLOGY | 2010年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I98 / I98
页数：1
相关论文
共 50 条
  • [41] Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
    Gladman, Dafna
    Rigby, William
    Azevedo, Valderilio F.
    Behrens, Frank
    Blanco, Ricardo
    Kaszuba, Andrzej
    Kudlacz, Elizabeth
    Wang, Cunshan
    Menon, Sujatha
    Hendrikx, Thijs
    Kanik, Keith S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (16): : 1525 - 1536
  • [42] Prolonged efficacy of rituximab in rheumatoid arthritis patients and inadequate response to one or more TNF inhibitors: 1-year follow-up of a subset of patients receiving a single course in a controlled trial (reflex study)
    Cohen, Stanley
    Cividino, Alfred
    Emery, Paul
    Greenwald, Maria
    Dougados, Maxime
    Furie, Richard
    Burmester, Gerd-Rudiger
    Williams, S.
    Cravets, Matthew
    Magrini, F.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1604 - 1605
  • [43] Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab
    Breedveld, F. C.
    Khraishi, M. M.
    Genovese, M.
    Emery, P.
    Moreland, L. W.
    Keystone, E.
    Matteson, E. L.
    Burke, L.
    Agarwal, S.
    Kim, D.
    Cooper, S.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1602 - 1602
  • [44] TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab.
    Genovese, M.
    Breedveld, F. C.
    Emery, P.
    Moreland, L. W.
    Keystone, E.
    Matteson, E. L.
    Burke, L.
    Agarwal, S.
    Kim, D.
    Cooper, S.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S329 - S329
  • [45] Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab
    Breedveld, F. C.
    Genovese, M.
    Emery, P.
    Moreland, L. W.
    Keystone, E.
    Matteson, E. L.
    Burke, L.
    Agarwal, S.
    Kim, D.
    Cooper, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 178 - 179
  • [46] Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab
    Breedveld, F. C.
    van Vollenhoven, R. F.
    Genovese, M.
    Emery, P.
    Moreland, L. W.
    Keystone, E.
    Matteson, E. L.
    Burke, L.
    Agarwal, S.
    Kim, D.
    Cooper, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 11 - 11
  • [47] Prolonged efficacy of rituximab in rheumatoid arthritis patients with inadequate response to one or more TNF inhibitors: 1-year follow-up of a subset of patients receiving a single course in a controlled trial (Reflex study)
    Cohen, S.
    Emery, P.
    Greenwald, M.
    Dougados, M.
    Furie, R.
    Burmester, G.
    Williams, S.
    Cravets, M.
    Magrini, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 183 - 183
  • [48] Tocilizumab (TCZ) Rapidly and Significantly Improves Outcomes in Patients with Rheumatoid Arthritis (RA) Who Have Inadequate Response (IR) to TNF Antagonists
    Pope, Janet
    Emery, Paul
    Keystone, Edward C.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2579 - 2579
  • [49] Patients achieve significant improvement in rheumatoid arthritis (RA) outcomes with tociluzumab (TCZ) regardless of prior inadequate response (IR) to TNF antagonists
    Emery, P.
    Keystone, E.
    Tony, H. P.
    Law, A.
    Woodworth, T.
    Kremer, J.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S533 - S533
  • [50] Tociluzumab (TCZ) improves quality of life (QOL) in patients with rheumatoid arthritis (RA) who had inadequate response (IR) to TNF antagonists
    Kremer, J.
    Pope, J.
    Ton, H. P.
    Burmester, G. R.
    Hall, S.
    Euller-Ziegler, L.
    Woodworth, T.
    Alecock, E.
    Emery, P.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S533 - S534
12345